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Abstracts / Journal of Nutrition & Intermediary Metabolism 4 (2016) 6e4714a-carotene (p ¼ 0.018) and b-carotene signiﬁcantly increased (p ¼ 0.013).
Older age (p ¼ 0.025), higher pre-intervention uncontrolled eating (p <
0.001) and plasma carotenoids (p ¼ 0.009) predicted weight-loss.
Conclusions: This study provides data which contributes to the charac-
terisation of nutritional biomarkers in obese COPD patients. We have also
demonstrated the efﬁcacy of a weight-loss intervention in improving diet
quality in this population. Future studies are needed to conﬁrm these
ﬁndings, and examine the long-term efﬁcacy of the weight-loss
intervention.
Funding source(s): John Hunter Hospital Charitable Trust Research Grants
Scheme.
EFFECTS OF WEIGHT LOSS AND DIETARY QUALITY ON ENDOTHELIAL
FUNCTION e A PILOT STUDY
N.B. Lister, K.S. Petersen, P.M. Clifton, J.B. Keogh. School of Pharmacy and
Medical Science, University of South Australia, SA, Australia
E-mail address: blany006@mymail.unisa.edu.au (N.B. Lister)
Background/Aims: Improved ﬂow mediated dilatation (FMD) has been
reported in some but not all weight loss studies. Restricting sodium is
known to improve FMD. It is unclear whether weight loss combined with
reduced sodium will have a greater beneﬁt on FMD. This study aimed to
determine the effects of weight loss and reduced sodium intake on FMD.
Methods: Participants were randomly assigned to two groups, in a parallel
design. All participants reduced sodium intake by 50 mmol for one week.
Group 1 (weight loss) then used low sodiummeal replacements for weight
loss, and Group 2 (control, no weight loss) continued their usual diet for 8
weeks. Adherence was assessed using 24 hr urinary sodium excretion.
FMD, blood pressure (BP), and 24 hr urinalysis were measured at baseline
and at completion of each intervention phase.
Results: Twenty-ﬁve participants (14 women; BMI: 34.7 ± 5.9 kg/m2; age:
42 ± 16 y) were enrolled and 23 participants completed the protocol. FMD
(2.3 ± 1.1%, p ¼ 0.04, n ¼ 25) and DBP (-2.7 ± 10mmHg, p ¼ 0.01, n ¼ 25)
improved after the sodium reduction. During the weight loss phase, mean
weight changewas -3.0 ± 3.3 kg Group 1 (n¼ 13) and +1.1 ± 1.2 kg Group 2
(n¼ 10), p¼ 0.02. There were no between group differences in FMD during
the weight loss phase. Urinary sodium decreased in Group 1 (-87 ± 18
mmol/d, p < 0.01) and Group 2 (-95 ± 25 mmol/d, p < 0.01) during sodium
restriction, and remained lower (Group 1: -67 ± 20 mmol/d, p ¼ 0.01;
Group 2: -69 ± 24 mmol/d, p ¼ 0.02) during the weight loss phase.
Conclusions: These results suggest reducing sodium intake improves FMD
but the combination of modest weight loss does not provide additional
beneﬁt.
Funding source(s): Heart Foundation and Government of South Australia.
EMU OIL PROMOTES BODYWEIGHT GAIN IN A MOUSE MODEL OF
INFLAMMATION-ASSOCIATED COLORECTAL CANCER
S. Mashtoub 1,2, G.S. Howarth 1,3, D. Trinder 2, I.C.
Lawrance 2. 1Gastroenterology Department, Women's & Children's Hospital,
North Adelaide, SA, Australia; 2 School of Medicine & Pharmacology, The
University of Western Australia, WA, Australia; 3 School of Animal &
Veterinary Sciences, The University of Adelaide, SA, Australia
E-mail address: suzanne.mashtoub@uwa.edu.au (S. Mashtoub)
Background/Aims: Patients suffering from the inﬂammatory disorder ul-
cerative colitis (UC) have an increased risk of developing colorectal cancer
(CRC). Previously, we demonstrated that Emu Oil (EO) reduced inﬂam-
mation and protected the intestine against UC, NSAID-enteropathy and
chemotherapy-inducedmucositis. We aimed to determine whether orally-
administered EO could reduce the severity of inﬂammation-associated CRC
in mice.
Methods:Mice (n¼ 8 per group) were orally-administered either water or
EO (EO1: 80 mL or EO2: 160 mL), thrice weekly. Mice were injected with
azoxymethane (AOM), followed by 3 cycles each consisting of 7 days
dextran sulphate sodium (DSS) and 14 days drinking water; and culled 3
weeks after the last cycle. Bodyweights, organ data and colonic tumour
numbers were recorded. P < 0.05 was considered signiﬁcant.
Results: During the ﬁrst 2 DSS-weeks, AOM/DSS decreased bodyweightgain compared to normal controls (maximum 23%; p < 0.05). However, in
AOM/DSS mice, EO2 increased bodyweight gain compared to untreated
and EO1-treated mice (maximum 10%; p < 0.05) during the 3rd DSS-week
until cull. Spleen weight was greater in AOM/DSS-treated mice (water: 0.3
± 0.03%; EO1: 0.3 ± 0.05%; EO2: 0.3 ± 0.03% relative to bodyweight)
compared to normal controls (0.2 ± 0.05%; p < 0.05). Thymus weight
decreased only in AOM/DSS control mice, compared to normal controls (p
< 0.05). AOM/DSS resulted in CRC development (water: 10.1 ± 1.7; EO1:
10.3 ± 1.2; EO2: 9.4 ± 1.7 tumour count) compared to normal controls (0 ±
0; p < 0.05).
Conclusions: Despite improved bodyweight, emu oil did not decrease the
number of colonic tumours. Further studies underway include assess-
ments of tumour size, histological morphometry, apoptosis and prolifer-
ation and pro-inﬂammatory cytokines.
Funding source(s): Cancer Council of Western Australia.
EFFECT OF COMBINED FISH OIL PLUS COENZYME Q10
SUPPLEMENTATION ON OMEGA-3 INDEX AND CARDIOVASCULAR RISK
MARKERS IN OVERWEIGHT MEN
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Background/Aims: A high Omega-3 Index is associated with a lower risk
of sudden cardiac death, and dietary ﬁsh oil supplementation has been
shown to improve cardiovascular disease (CVD) risk factors. There is little
research examining CVD risk factor modiﬁcation resulting from change in
the Omega-3 Index due to ﬁsh oil supplementation. We aimed to assess
the effects of 12 weeks ﬁsh oil supplementation on change in Omega-3
Index together with CVD risk factors.
Methods: Fifty overweight men were randomised to receive ﬁsh oil (1728
mg ﬁsh oil containing 1000mg EPA + DHA per day) combined with 200mg
antioxidant (coenzyme Q10), or placebo (2 g olive oil) for 12 weeks.
Anthropometry and biochemical outcomes were measured at baseline, six
and 12 weeks supplementation. Relationships between change in Omega-
3 Index and change in anthropometric and biochemical outcomes were
examined by linear regression.
Results: Forty-eight men completed the trial. Baseline Omega-3 Index was
high in both the ﬁsh oil and placebo groups (7.9 ± 0.4% and 8.1 ± 0.3%,
respectively). Fish oil supplementation resulted in a large and signiﬁcant
increase in Omega-3 Index (D 2.8 ± 0.3%), whereas placebo supplemen-
tation did not (D 0.3 ± 0.2%, p < 0.001). There was no signiﬁcant effect of
change in Omega-3 Index on CVD risk markers (p > 0.05 for all).
Conclusions: In overweight menwith a high baseline Omega-3 Index ﬁsh,
oil supplementation increased the Omega-3 Index but this was not asso-
ciated with improvement in CVD risk markers.
Funding source(s): Blackmores Australia Ltd.
RESISTIN AND RESISTIN:ADIPONECTIN RATIO PREDICT LUNG FUNCTION
IN ASTHMA
L.G. Wood, D. Ballantyne, H.A. Scott, L. MacDonald-Wicks, P.G.
Gibson. University of Newcastle, NSW, Australia
E-mail address: lisa.wood@newcastle.edu.au (L.G. Wood)
Background/Aims: Adipokines, such as resistin and adiponectin, may
contribute to increased asthma risk and severity in obese people. We
aimed to examine plasma resistin and resistin:adiponectin ratio in asth-
matics compared to healthy controls, according to asthma severity, BMI
and gender, following weight loss in obese asthmatics.
Methods: In a cross-sectional observational study of asthmatic adults (n ¼
96) and healthy controls (n ¼ 46), plasma resistin and adiponectin were
measured. In a separate intervention study, obese asthmatic adults (n ¼
27) completed a 10-weekweight-loss intervention and plasma resistin and
adiponectin were measured.
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asthma compared to controls [7.2 (4.8-9.6) vs. 4.8 (3.7-7.3) ng/mL, p ¼
0.005 and 3.04 ± 0.58 vs. 1.55 ± 0.23  10-3, p ¼ 0.019 respectively] and
further increased in subjects with a severe asthma pattern. Resistin:adi-
ponectin ratio was increased in obese asthma compared to non-obese
asthma and non-obese controls. Resistin:adiponectin ratio was increased
in obese females, non-obese males and obese males compared to non-
obese females. Using multiple linear regression, both resistin and resisti-
n:adiponectin negatively predicted lung function. Following weight loss,
resistin and resistin:adiponectin ratio were unchanged. However, change
in %body fat was associated with change in resistin:adiponectin ratio.
Conclusions: Resistin:adiponectin ratio is increased in asthma and further
increased in subjects who are obese, have more severe disease and are
male. As resistin and resistin:adiponectin ratio negatively predict lung
function, these adipokines may provide a therapeutic target for obese
asthma.
Funding source(s): Hunter Medical Research Institute.
ADULT SNACKING IN AUSTRALIA: UNDERSTANDING WHO, WHAT,
WHEN AND HOW MUCH
F.F. Fayet-Moore, A.A. McConnell, T.T. Keighley. Nutrition Research
Australia, NSW, Australia
E-mail address: andrew@nraus.com (A.A. McConnell)
Background/Aims: There are limited data on snacking behaviour of
Australian adults.
Methods:Weekday data from the 2011-12 National Nutrition and Physical
Activity Survey were used. Eating occasion (EO) was deﬁned as any food or
beverage consumed at a unique time. A snacking occasion (SO) was
deﬁned as an EO during a 'between main meal' time period. Daily number
of EO, SO, items consumed, %energy contribution of SO and discretionary
energy intake were determined and multiple linear regressionwas used to
adjust for confounders.
Results: Adults consumed on average 7 EO and 2 SO per day. Adults
consumed 4 items per day from all SO compared to 14 items from all main
meals, and 88% of adults had at least 1 SO/day. The most popular SO was
the morning (69%) and provided an average of 12.6% of total energy intake.
Higher SO/day was associated with greater total energy intake, similar BMI
and waist circumference compared to lower SO/day. SO contributed 22% of
total energy and between 16%-32% of total nutrient intake. All SO com-
bined contributed 29% of total discretionary energy intake, whereas the
evening main meal contributed 44%. The top three food groups that
contributed the most energy during SO were; cakes, mufﬁns, scones, cake-
type desserts; regular breads, and bread rolls; and dairy milk.
Conclusions: Snacking behaviour was prominent among adults but
contributed less than a quarter of total energy intake. The evening main
meal contributed the most discretionary energy and needs further
investigation.
Funding source(s): Nestle Australia Ltd.
THE DIETARY MODELLING TOOL: USING ONLINE CONSTRAINT
OPTIMISATION TECHNIQUES TO STREAMLINE FOOD-BASED DIETARY
PRESCRIPTIONS
Y.C. Probst, E. Sullivan, E. Morrison, H.K. Dam. University of Wollongong,
NSW, Australia
E-mail address: yasmine@uow.edu.au (Y.C. Probst)
Background/Aims: Standardised background diets for participants of
food-based randomised trials are vital. For this, dietarymodelling based on
the percentage contributions from macronutrients or particular food
group and their serving sizes is employed. Modelling accuracy is critical to
assuring reliability and validity of the research and can signiﬁcantly impact
on the translation to practice. This study describes the development of the
dietary modelling tool and its relative validity compared to manual and
semi-automated approaches to modelling.
Methods: Constraint optimisation techniques were used to determine
whether non-linear constraints are best suited to the development of
the automated modelling tool. Using standard practice as a reference,dietary models were produced and compared (manual and semi-
automated).
Results: The Dietary Modelling Tool was produced online using constraint
optimisation, incorporating estimated energy requirement calculations
and based on Australian food guidance systems. Output for all tools was
the number of food group servings required by a person of given energy
requirements, to meet the macronutrient criteria of a hypothetical study.
Percentage differences between tools revealed similar results across
modelling tools. Poly-unsaturated fatty acids and monounsaturated fatty
acids showed the most variation (up to 200%) across tools, though not
clinically signiﬁcant (equating to 2 tsp difference).
Conclusions: Automated modelling tools can streamline the modelling
process for food-based trials, however, appropriate constraints must be
entered to achieve desired results. Relatively, similar results were found
with less automation, suggesting interchangeability of tools though
implementation should reﬂect the requirements and capacity of study.
Funding source(s): University of Wollongong ECR grant.
WELLNESS, WELLBEING AND FOOD CHOICE CLINICAL PRACTICE TOOL e
A WAY FORWARD FOR PATIENT-CENTRED WEIGHT LOSS PRACTICE
A.T. McMahon, L. Tapsell, A. Lechner, K. Irwin. University of Wollongong,
NSW, Australia
E-mail address: ael581@uowmail.edu.au (A.T. McMahon)
Background/Aims: Evolving social constructs of health incorporating
concepts of wellness and wellbeing may challenge nutritionists with the
implementation of patient-centred interventions. This study aimed to
describe the two-stage development of a clinical questionnaire tool based
on a research derived Wellness, Wellbeing and Food Choice Framework
(WWFCF) to support patient-centred weight loss.
Methods: In stage one, existing validated questionnaires were reviewed to
identify suitable items related to themes and sub-themes developed
initially with female respondents. Male response data from the original
WWFCF study was also analysed using the coding framework from the
WWFCF to determine suitability and relevance of use of items in a male
population. Nvivo software was used to manage and organise this sec-
ondary qualitative analysis. At completion of stage one, a 23 item proto-
type questionnaire tool was developed. Stage two sought to reﬁne the tool
further by assessing face validity with ten experts in health academia.
Feedback from face validity identiﬁed ambiguous and/or inappropriate
items which were altered or eliminated. Structural changes were also
imposed based on face validity data to improve the clarity of the ques-
tionnaire tool.
Results: The ﬁnal prototype developed is a self-report questionnaire tool,
consisting of 21 items reﬂecting the key themes of theWWFCF framework.
Conclusions: The tool should allow nutritionists develop strategies
incorporating patient-centred approaches in weight loss intervention.
Further research is required to assess the suitability of the tool in actual
practice. The research thus far may act as a platform for further tests of
construct validity and reliability.
Funding source(s): Smart Foods Centre UOW.
DISCRETIONARY INTAKE AMONG ADULTS: TOP FOODS, TIME OF
CONSUMPTION AND ASSOCIATION WITH SEX, WEIGHT AND SOCIO-
ECONOMIC STATUS
F. Fayet-Moore 1, A. McConnell 1, C. Grant 2, P. Petocz 3. 1Nutrition Research
Australia, NSW, Australia; 2Nestle Australia Ltd., Rhodes, NSW, Australia;
3Macquarie University, NSW, Australia
E-mail address: ﬂavia@nraus.com (F. Fayet-Moore)
Background/Aims: Discretionary foods (DF) should be consumed occa-
sionally but contribute 35% of total energy intake (%en), highlighting the
need to proﬁle consumption.
Methods: Data from the 2011-12 National Nutrition and Physical Activity
Survey were used, including self-reported eating occasions (REO). Preva-
lence of consumption, DF serves (1 ¼ 600 kJ), nutrient contribution from
DF and top DF food groups by REO were calculated by age, gender, socio-
economic status (SES) and weight status. DF consumers (> 0 grams) were
